ATRC
HOLD / NEUTRALMeanRevComposite
56.00
Technical
86.40
Fundamental
45.90
Rank
—
Price
37.37
Hurst
0.38
As of
Jul 28, 2026
Daily
AtriCure, Inc.
HealthcareMedical Instruments & SuppliesAtriCure develops and manufactures medical devices used in cardiac surgery, including systems for ablating heart tissue, closing the left atrial appendage, and managing atrial fibrillation through radiofrequency and cryoablation technologies. The company also produces devices for temporary nerve pain relief and supplies complementary surgical instruments and accessories. AtriCure sells its products to hospitals and medical centers globally through a combination of direct sales and independent distributors.
Market cap
$3.0B
P/E (trailing)
268.73
P/E (forward)
136.93
PEG ratio
10.00
Dividend yield
—
Beta
1.26
52w range
25.36 – 59.59
Return on equity
+2.15%
Profit margin
+1.85%
Revenue growth
+12.80%
Earnings growth
—
Price history
1Y: 59.12 (+61.3%) · range 25.86–59.12
Cycle position
88/ 100 cycle scoreEXIT ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 0 · NOT READY · exit proximity 70
Conviction
21/ 100 · maturity 100%
VScore.4013
Buildup.2043
EMA entry setup.250
Fundamentals.1546
Volume profile
POC
28.44
Price vs POC
+107.9%
Overhead supply
0%
Runway
open sky
Value area 25.36–39.05 · 0% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| congressional-trading | 0.000 | Sep 17, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +22.47% | +23.97% | mature |
| 40d | +37.21% | +37.21% | 32/40d |